A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
Conditions
Adenocarcinoma of the Rectum · Locally Advanced Rectal Adenocarcinoma · Rectal Adenocarcinoma · HER2 Positive Rectal Adenocarcinoma · Rectal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
Contact: Principal Investigator (Andrea Cercek, MD)Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
Study leads
Andrea Cercek, MD
Principal Investigator
Memorial Sloan Kettering Cancer